Humanized anti CD-20 as an alternative in chronic management of relapsing thrombotic thrombocytopenic microangiopathy resistant to rituximab due to anti chimeric antibody. - Ahmadpoor P; Aglae C; Garo F; Cariou S; Renaud S; Reboul P; Moranne O (International journal of hematology, 2021)